000			01916 a2200541 4500
005			20250517165312.0
264		0	_c20180711
008			201807s 0 0 eng d
022			_a1582-4934
024	7		_a10.1111/jcmm.13261 _2doi
040			_aNLM _beng _cNLM
100	1		_aYin, Jianyong
245	0	0	_aAntithrombin III prevents progression of chronic kidney disease following experimental ischaemic-reperfusion injury. _h[electronic resource]
260			_bJournal of cellular and molecular medicine _cDec 2017
300			_a3506-3514 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aActins _xantagonists & inhibitors
650	0	4	_aAcute Kidney Injury _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntithrombin III _xpharmacology
650	0	4	_aCollagen Type I _xantagonists & inhibitors
650	0	4	_aDisease Models, Animal
650	0	4	_aDisease Progression
650	0	4	_aFibronectins _xantagonists & inhibitors
650	0	4	_aFibrosis
650	0	4	_aGene Expression Regulation _xdrug effects
650	0	4	_aInterleukin-1beta _xantagonists & inhibitors
650	0	4	_aKidney _xdrug effects
650	0	4	_aMacrophages _xdrug effects
650	0	4	_aMale
650	0	4	_aNephrectomy
650	0	4	_aNitric Oxide Synthase Type II _xantagonists & inhibitors
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReperfusion Injury _xgenetics
650	0	4	_aSignal Transduction
650	0	4	_aTumor Necrosis Factor-alpha _xantagonists & inhibitors
700	1		_aWang, Feng
700	1		_aKong, Yiwei
700	1		_aWu, Rui
700	1		_aZhang, Guangyuan
700	1		_aWang, Niansong
700	1		_aWang, Ling
700	1		_aLu, Zeyuan
700	1		_aLiang, Mingyu
773	0		_tJournal of cellular and molecular medicine _gvol. 21 _gno. 12 _gp. 3506-3514
856	4	0	_uhttps://doi.org/10.1111/jcmm.13261 _zAvailable from publisher's website
999			_c27425469 _d27425469